CCM
CL icon

Coldstream Capital Management’s Colgate-Palmolive CL Stock Holding History

Coldstream Capital Management’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.01M Buy
21,954
+888
+4% +$77.7K 0.03% 307
2026
Q1 		$1.8M Buy
21,066
+6,670
+46% +$594K 0.02% 328
2025
Q4 		$1.14M Sell
14,396
-40,410
-74% -$3.17M 0.01% 412
2025
Q3 		$4.38M Buy
54,806
+9,184
+20% +$783K 0.06% 164
2025
Q2 		$4.15M Buy
45,622
+31,833
+231% +$2.91M 0.07% 160
2025
Q1 		$1.29M Buy
13,789
+236
+2% +$21.1K 0.03% 331
2024
Q4 		$1.23M Buy
13,553
+1,854
+16% +$177K 0.03% 342
2024
Q3 		$1.2M Buy
11,699
+990
+9% +$101K 0.03% 329
2024
Q2 		$1.04M Buy
10,709
+221
+2% +$20.4K 0.03% 322
2024
Q1 		$944K Sell
10,488
-41
-0.4% -$3.47K 0.02% 335
2023
Q4 		$839K Buy
10,529
+653
+7% +$49.1K 0.02% 329
2023
Q3 		$702K Buy
9,876
+1,169
+13% +$87.4K 0.02% 329
2023
Q2 		$671K Sell
8,707
-481
-5% -$37.2K 0.02% 353
2023
Q1 		$690K Sell
9,188
-32
-0.3% -$2.38K 0.02% 342
2022
Q4 		$726K Buy
+9,220
New +$691K 0.03% 323
2022
Q2 		$981K Buy
12,233
+2,675
+28% +$209K 0.04% 242
2022
Q1 		$725K Sell
9,558
-2,387
-20% -$189K 0.03% 282
2021
Q4 		$1.02M Buy
11,945
+2,787
+30% +$218K 0.03% 244
2021
Q3 		$707K Buy
9,158
+992
+12% +$78.8K 0.03% 218
2021
Q2 		$664K Sell
8,166
-283
-3% -$23.1K 0.03% 242
2021
Q1 		$666K Buy
8,449
+422
+5% +$33.1K 0.04% 194
2020
Q4 		$686K Buy
8,027
+1,460
+22% +$121K 0.04% 186
2020
Q3 		$507K Sell
6,567
-32
-0.5% -$2.44K 0.04% 186
2020
Q2 		$483K Buy
6,599
+3,451
+110% +$245K 0.04% 190
2020
Q1 		$209K Buy
+3,148
New +$222K 0.02% 254
2017
Q4 		– Sell
-3,297
Closed -$240K – 318
2017
Q3 		$240K Buy
+3,297
New +$238K 0.03% 261

Other funds holding CL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Coldstream Capital Management's CL Position: Q2 2026 in Review

Coldstream Capital Management increased its Colgate-Palmolive (CL) stake by 4.2% in Q2 2026, buying an estimated $77.7K and bringing the position to 21,954 shares worth $2.01M. The position accounts for 0.03% of the portfolio, ranked #307.

Coldstream Capital Management first reported a position in CL in Q3 2017 and has held it in 26 quarters since. The position peaked at $4.38M in Q3 2025. 2,028 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Coldstream Capital Management held 21,954 shares of Colgate-Palmolive worth $2.01M as of Q2 2026.
  • Coldstream Capital Management bought 888 Colgate-Palmolive shares in Q2 2026, an estimated $77.7K.
  • Colgate-Palmolive made up 0.03% of Coldstream Capital Management's portfolio in Q2 2026, its #307 holding.
  • Coldstream Capital Management first reported a position in Colgate-Palmolive in Q3 2017 and has held it in 26 quarters since.
  • Coldstream Capital Management's Colgate-Palmolive position peaked at $4.38M in Q3 2025.
  • 2,028 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Coldstream Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.